243 related articles for article (PubMed ID: 31418375)
1. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
Zhao D; Jiang JQ; Lin L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].
Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051
[TBL] [Abstract][Full Text] [Related]
3. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
4. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
[TBL] [Abstract][Full Text] [Related]
6. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
[TBL] [Abstract][Full Text] [Related]
7. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
8. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
Lu H; Zhang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
[TBL] [Abstract][Full Text] [Related]
9. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma].
Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871
[TBL] [Abstract][Full Text] [Related]
10. [Value of Serum Free Light Chain Kappa/Lambda Ratio Detection Combined with Immunofixation Electrophoresis in the Prognosis Evaluation of Patients with Multiple Myeloma].
Jiang XN; Chen JF; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):191-195. PubMed ID: 32027275
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Serum Free Light Chain Ratio and Normalization Ratio after Treatment on Diagnosis and Prognosis of Patients with Newly Diagnosed Multiple Myeloma].
Li ZQ; Tian WW; Guo YF; Ma LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1245-1250. PubMed ID: 32798406
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between Serum Free Light Chain and Blood Routine Parameters in Patients with Multiple Myeloma].
Li D; Jiang N; Wang JQ; Wang ZB; He Y; Zhang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1446-1452. PubMed ID: 36208248
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma].
Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070
[TBL] [Abstract][Full Text] [Related]
15. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of Heavy/ Light Chain Pairs of Immunoglobulin (Hevylite assay) - Benefit for Stratification of Multiple Myeloma?].
Ščudla V; Lochaman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Klin Onkol; 2015; 28(5):359-69. PubMed ID: 26480864
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic value of baseline serum free light chain in cardiac amyloidosis].
Zhao L; Tian Z; Fang Q
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Relationship between Serum Total Light Chain κ/λ Ratio and Proportion of Bone Marrow Plasma Cells in Patients with IgG type and IgA type Multiple Myeloma].
Zhu AY; Zhu FB; Wang FC; Zhang LJ; Ma Y; Hu JG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1454-1459. PubMed ID: 29070124
[TBL] [Abstract][Full Text] [Related]
19. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Serum Free Light Chain in Multiple Myeloma.
El Naggar AA; El-Naggar M; Mokhamer el-H; Avad MW
Egypt J Immunol; 2015; 22(1):69-78. PubMed ID: 26415374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]